Kenneth Ferguson
Director/Board Member at CYCLACEL PHARMACEUTICALS, INC.
Net worth: 10 230 $ as of 31/05/2024
Profile
Kenneth M.
Ferguson is currently the Director at Cyclacel Pharmaceuticals, Inc. and an Operating Partner at Accelerator Services Corp.
Previously, he was the President, Chief Executive Officer & Director at Vactx International, Inc. from 2008 to 2010, COO, Chief Scientific Officer & Director at Lilly ICOS LLC, and President at ICOS Corp.
from 1990 to 2007.
He also served as the Chief Development Officer & Vice President at Omeros Corp.
from 2012 to 2017 and as the Chief Scientific Officer at EMulate Therapeutics, Inc. Dr. Ferguson received his undergraduate degree from Cornell University and his doctorate from Texas University of Health Center at San Antonio.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/05/2024 | 3,875 ( 0.26% ) | 10 230 $ | 31/05/2024 |
Kenneth Ferguson active positions
| Companies | Position | Start |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Director/Board Member | 14/06/2022 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Private Equity Investor | - |
Former positions of Kenneth Ferguson
| Companies | Position | End |
|---|---|---|
| OMEROS CORPORATION | Corporate Officer/Principal | 01/05/2017 |
| Vactx International, Inc. | Chief Executive Officer | 01/11/2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | President | 01/12/2007 |
EMulate Therapeutics, Inc.
 EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Chief Tech/Sci/R&D Officer | - |
Lilly ICOS LLC
 Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Chief Tech/Sci/R&D Officer | - |
Training of Kenneth Ferguson
| Texas University of Health Center at San Antonio | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Vactx International, Inc. | |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Lilly ICOS LLC
Lilly ICOS LLC Pharmaceuticals: MajorHealth Technology Lilly ICOS LLC develops and markets medical drugs. It produces Cialis drug which is used for the treatment of erectile dysfunction. The firm's competitors are Viagra and Levitra. The company was founded in October 1998 and is headquartered in Indianapolis, IN. | Health Technology |
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. Medical SpecialtiesHealth Technology EMulate Therapeutics, Inc. is a clinical-stage therapeutic device company, which engages in the business of developing noninvasive therapies for cancers and other serious diseases. The firm is also involved in developing treatments for multiple disease areas that affect human health. The company was founded by Bennett Mike Butters and John Kingma on February 7, 2002 and is headquartered in Bellevue, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
- Stock Market
- Insiders
- Kenneth Ferguson
